108 Results for "

LXR

" in MedChemExpress (MCE) Product Catalog:
Products (108)

108 Results for "LXR" in MCE Product Catalog:

  • Categories Recommended:
    More
Cat. No.: HY-160038
CAS No.: 929492-71-7
Target:  

LXR

Research Areas:  

Cancer

GAC0003A4 is an LXR inverse agonist that inhibits LXR transcriptional activity. GAC0003A4 also efficiently degrades LXRβ protein. GAC0003A4 has the potential to be used in advanced pancreatic cancer and other refractory malignancies .
loading...
    loading...
Cat. No.: HY-160039
CAS No.: 927969-67-3
Target:  

LXR

Research Areas:  

Cancer

GAC0001E5 is an LXR inverse agonist. GAC0001E5 has antiproliferative activity and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-125772
CAS No.: 344327-48-6
Purity:  ≥99.0%
Synonyms: Acetylpodocarpic dimer; APD
Target:  

LXR

Research Areas:  

Cardiovascular Disease

Acetyl podocarpic acid anhydride is a potent, semisynthetic liver X receptor(LXR) agonist derived from extracts of the mayapple. Acetyl podocarpic acid anhydride has the potential to be useful for the prevention and research of atherosclerosis, especially in the context of low HDL levels .
loading...
    loading...
Cat. No.: HY-W587772
CAS No.: 1684398-38-6
Synonyms: MEHHTP
Target:  

Drug Metabolite

Research Areas:  

Metabolic Disease

Mono (2-ethyl-5-hydroxyhexyl) terephthalate (MEHHTP), a hydroxyl metabolite of the phthalate alternative Di-2-ethylhexyl terephthalate (DEHTP), is a liver X receptor α (LXRα) agonist with a binding energy of -7.41 kcal/mol. Mono (2-ethyl-5-hydroxyhexyl) terephthalate upregulates LXRα downstream targets such as SREBP-1c and FASN and increases lipogenic enzyme activity in hepatocytes, and elevating triglyceride (TG) levels. Mono (2-ethyl-5-hydroxyhexyl) terephthalate is promising for research of nonalcoholic fatty liver disease (NAFLD) .
loading...
    loading...
Cat. No.: HY-176236
Target:  

LXR Autophagy

Research Areas:  

Metabolic Disease

Lipophagy inducer 1 is a lipophagy inducer. Lipophagy inducer 1 has activity of reducing lipid droplet accumulation and rescuing cell death. Lipophagy inducer 1 exerts its effects by activating lipophagy, increasing steady-state autophagosome and regulating the LXR signaling pathway. Lipophagy inducer 1 can be used in the study of diabetic nephropathy (DKD) and other diseases related to lipid metabolism disorders .
loading...
    loading...
Cat. No.: HY-149132
CAS No.: 1191043-85-2
Purity:  96.7%
Synonyms: DDA
Dendrogenin A (DDA) is a ligand for liver X receptor (LXR), that induces the expression of sodium/iodine symporter, and increases iodine uptake. Dendrogenin A induces cell differentiation of MCF-7, and reactivates the function of lactating cells. Dendrogenin A induces the expressions of the TSH receptor, thyroid peroxidase, and thyroglobulin, and affects thyroid hormone generation. Dendrogenin A exhibits cytotoxicity in cancer cell B-CPAP and 8505c with IC50 of 4.1 and 6.2 µM. Dendrogenin A arrests the cell cycle at G0/G1 phase .
loading...
    loading...
Cat. No.: HY-D1734
CAS No.: 2374144-23-5
FITC-GW3965 is a fluorescence-labelled liver X receptor β (LXRβ) agonist GW3965 (HY-10627). FITC-GW3965 is a tracer, that can be designed by replacing the trifluoromethyl of GW3965 with an amide to link the FITC. FITC-GW3965 can be used to study the function of LXRβ .
loading...
    loading...
Cat. No.: HY-N2370R
CAS No.: 30271-38-6
24-Hydroxycholesterol is a natural sterol, which serves as a positive allosteric modulator of N-Methyl-d-Aspartate (NMDA) receptorsR, and a potent activator of the transcription factors LXR.
loading...
    loading...
Cat. No.: HY-139576
CAS No.: 884905-07-1
Synonyms: DUR-928
Larsucosterol (DUR-928), a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol as a potent endogenous regulator decreases lipogenesis. Larsucosterol inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1 .
loading...
    loading...
Cat. No.: HY-143259
CAS No.: 2893967-40-1
Purity:  99.86%
Target:  

LXR

Research Areas:  

Cancer

BE1218 is a liver X receptor (LXR) inverse agonist with IC50 values of 9 nM and 7 nM against LXRα and LXRβ, respectively .
loading...
    loading...
Cat. No.: HY-33821
CAS No.: 171049-41-5
Target:  

LXR

Research Areas:  

Others

LXRβ ligand 1 is a LXR β ligand-binding domain agonist, with an EC50 of 57 μM and a Ki of 28 μM against human LXR β. LXRβ ligand 1 forms hydrogen bonds with His435, stabilizes the His-Trp activation switch, and locks the ligand-binding domain in an agonist conformation; its tert-butyl moiety occupies a hydrophobic subpocket, while its phenyl moiety forms a π-π stacking interaction with Phe329. LXRβ ligand 1 serves as a structural unit for the development of LXRβ modulators .
loading...
    loading...
Cat. No.: HY-154928
CAS No.: 405910-78-3
Purity:  98.69%
Target:  

LXR

Research Areas:  

Metabolic Disease

GW6340 is an intestinal-specific LXR agonist. GW6340 promotes macrophage reverse cholesterol transport (mRCT) .
loading...
    loading...
Cat. No.: HY-133830
CAS No.: 245523-67-5
Synonyms: (3β,7α,24S)-Cholest-5-ene-3,7,24-triol
Target:  

Endogenous Metabolite

Research Areas:  

Others

7α,24(S)-Dihydroxycholesterol ((3β,7α,24S)-Cholest-5-ene-3,7,24-triol) serves as a ligand for liver X receptor (LXR), binding specifically to the ligand binding domains of both LXRα and LXRβ. This compound is synthetically produced from E-α,β-enone, utilizing Arsonium ylide and J-tert-butyldimethylsilyloxy-bisnor-5-cholenaldehyde as starting materials, followed by a series of transformations to yield 7α,24(S)-dihydroxycholesterol.
loading...
    loading...
Cat. No.: HY-138007
CAS No.: 1414248-06-8
Target:  

ROR PPAR LXR

SR-1903 is an inverse agonist of RORγ and PPARγ (IC50 of ∼100 nM and 209 nM for RORγ and PPARγ, respectively) and a LXR agonist. SR-1903 exhibits anti-inflammatory and anti-diabetic efficacy in collagen-induced arthritis and diet-induced obesity mouse models .
loading...
    loading...
Cat. No.: HY-169159
CAS No.: 2867630-96-2
Target:  

Sirtuin

Research Areas:  

Metabolic Disease

SIRT6 activator 2 (compound 31) is a sirtuin 6 activator with anti-lipid accumulation properties. SIRT6 activator 2 significantly downregulates LXR, SREBP-1c, and their target genes associated with lipogenesis, and can be used for research related to lipid metabolism-related diseases .
loading...
    loading...
Cat. No.: HY-146288
CAS No.: 2978788-07-5
Target:  

LXR

Research Areas:  

Metabolic Disease

LXR agonist 2 (compound 18rr) is a potent LXR (liver X receptor) agonist. LXR agonist 2 can stabilize NCOA1 (co-activator), leading to LXR agonism .
loading...
    loading...
Cat. No.: HY-179278
Target:  

LXR

LXR agonist 4 is a selective LXR inverse agonist with IC50 values of 7.6 (LXRα) and 2.9 μM (LXRβ), respectively. LXR agonist 4 exhibits selectivity over RORα and FXR. LXR agonist 4 robustly suppresses SREBP1c expression without altering ABCA1 or APOE. LXR agonist 4 displays antilipogenic properties and resolves fatty acid-induced steatosis. LXR agonist 4 can be used for the research of atherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLD) .
loading...
    loading...
Cat. No.: HY-144554
CAS No.: 1779524-93-4
Research Areas:  

Cancer

Aminooxy CatB-LXR (compound 10) is a agent-linker conjugates for ADC .
loading...
    loading...
Cat. No.: HY-RS22684
Research Areas:  

Others

Nr1h3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nr1h3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-N2273
CAS No.: 19942-02-0
Gymnestrogenin is a pentahydroxytriterpene from the leaves of Gymnema sylvestre R.Br . Gymnestrogenin is a LXR antagonist with IC50s of 2.5 and 1.4 μM for LXRα and LXRβ transactivation, respectively. Gymnestrogenin reduces the transcriptional activity of LXR even on its own promoter, thus reducing the mRNA expression .
loading...
    loading...